Comparison Overview

Walmsley, Employee Assistance Programs

VS

Mira Therapeutics

Walmsley, Employee Assistance Programs

666 Burrard St, Vancouver, V6C 3P6, CA
Last Update: 2026-01-21
View Profile
Between 750 and 799
http://www.walmsley.ca

Just like our various offices, things are different at Walmsley, Employee and Family Assistance Programs. We know that "Being There Matters" We are a 100% Canadian owned, Stand-Alone EFAP. Walmsley, EFAP is known for and takes pride in, offering personalized and generous levels of service and support to employers and their employees. We have been building valuable partnerships with private and public sector organizations, unions, advisors and consultants since 1994. Walmsley, EFAP offers a generous, robust program that provides face-to-face, virtual and telephonic counselling services, via our vast network of master’s level counsellors, located throughout Canada. Our programs incorporate wellness initiatives and professional services to the organization as a whole; taking a holistic approach to service delivery, resulting in improved outcomes. Let’s Talk About Your Organization’s EFAP Needs

NAICS: 62133
NAICS Definition: Offices of Mental Health Practitioners (except Physicians)
Employees: 21
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Mira Therapeutics

undefined, Hoboken, NJ, 07030, US
Last Update: 2026-01-21
Between 750 and 799
https://miratx.app

Mira Therapeutics is a digital health company changing the way people recover and grow from trauma. Through a combination of self-management tools, symptom tracking, and a therapist platform, Mira Therapeutics empowers users to better cope with their symptoms, and enables therapists to deliver personalized, measurement-based care.  Our first product, the Mira App, helps users manage their symptoms when they occur, educates about trauma, and tracks events and triggers that inform treatment decisions.

NAICS: 621
NAICS Definition:
Employees: 1
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/walmsley.jpeg
Walmsley, Employee Assistance Programs
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/miratherapeutics.jpeg
Mira Therapeutics
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Walmsley, Employee Assistance Programs
100%
Compliance Rate
0/4 Standards Verified
Mira Therapeutics
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Mental Health Care Industry Average (This Year)

No incidents recorded for Walmsley, Employee Assistance Programs in 2026.

Incidents vs Mental Health Care Industry Average (This Year)

No incidents recorded for Mira Therapeutics in 2026.

Incident History — Walmsley, Employee Assistance Programs (X = Date, Y = Severity)

Walmsley, Employee Assistance Programs cyber incidents detection timeline including parent company and subsidiaries

Incident History — Mira Therapeutics (X = Date, Y = Severity)

Mira Therapeutics cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/walmsley.jpeg
Walmsley, Employee Assistance Programs
Incidents

No Incident

https://images.rankiteo.com/companyimages/miratherapeutics.jpeg
Mira Therapeutics
Incidents

No Incident

FAQ

Walmsley, Employee Assistance Programs company demonstrates a stronger AI Cybersecurity Score compared to Mira Therapeutics company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Mira Therapeutics company has disclosed a higher number of cyber incidents compared to Walmsley, Employee Assistance Programs company.

In the current year, Mira Therapeutics company and Walmsley, Employee Assistance Programs company have not reported any cyber incidents.

Neither Mira Therapeutics company nor Walmsley, Employee Assistance Programs company has reported experiencing a ransomware attack publicly.

Neither Mira Therapeutics company nor Walmsley, Employee Assistance Programs company has reported experiencing a data breach publicly.

Neither Mira Therapeutics company nor Walmsley, Employee Assistance Programs company has reported experiencing targeted cyberattacks publicly.

Neither Walmsley, Employee Assistance Programs company nor Mira Therapeutics company has reported experiencing or disclosing vulnerabilities publicly.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Walmsley, Employee Assistance Programs company nor Mira Therapeutics company has publicly disclosed detailed information about the number of their subsidiaries.

Walmsley, Employee Assistance Programs company employs more people globally than Mira Therapeutics company, reflecting its scale as a Mental Health Care.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds SOC 2 Type 1 certification.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds SOC 2 Type 2 certification.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds ISO 27001 certification.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds PCI DSS certification.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds HIPAA certification.

Neither Walmsley, Employee Assistance Programs nor Mira Therapeutics holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

SummaryA command injection vulnerability (CWE-78) has been found to exist in the `wrangler pages deploy` command. The issue occurs because the `--commit-hash` parameter is passed directly to a shell command without proper validation or sanitization, allowing an attacker with control of `--commit-hash` to execute arbitrary commands on the system running Wrangler. Root causeThe commitHash variable, derived from user input via the --commit-hash CLI argument, is interpolated directly into a shell command using template literals (e.g.,  execSync(`git show -s --format=%B ${commitHash}`)). Shell metacharacters are interpreted by the shell, enabling command execution. ImpactThis vulnerability is generally hard to exploit, as it requires --commit-hash to be attacker controlled. The vulnerability primarily affects CI/CD environments where `wrangler pages deploy` is used in automated pipelines and the --commit-hash parameter is populated from external, potentially untrusted sources. An attacker could exploit this to: * Run any shell command. * Exfiltrate environment variables. * Compromise the CI runner to install backdoors or modify build artifacts. Credits Disclosed responsibly by kny4hacker. Mitigation * Wrangler v4 users are requested to upgrade to Wrangler v4.59.1 or higher. * Wrangler v3 users are requested to upgrade to Wrangler v3.114.17 or higher. * Users on Wrangler v2 (EOL) should upgrade to a supported major version.

Published
Date
2026-01-20
Updated
Date
2026-01-20
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Published
Date
2026-01-20
Updated
Date
2026-01-20
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
References
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle VM VirtualBox accessible data as well as unauthorized access to critical data or complete access to all Oracle VM VirtualBox accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L).

Published
Date
2026-01-20
Updated
Date
2026-01-20
Risk Information
cvss3
Base: 8.1
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L
References
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Published
Date
2026-01-20
Updated
Date
2026-01-20
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
References
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Published
Date
2026-01-20
Updated
Date
2026-01-20
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
References